Alleviative effects of deep-seawater drinking water on hepatic lipid accumulation and oxidation induced by a high-fat diet

Journal of the Chinese Medical Association

Volumn 76, Issue 2, 2013, Pages 95-101

  Chen, I Shu ^a   Chang, Yuan Yen ^b   Hsu, Chin Lin ^b   Lin, Hui Wen ^c   Chang, Ming Hsu ^d   Chen, Jr Wei ^e   Chen, Sheng Shih ^a   Chen, Yi Chen ^f  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^d NATIONAL KAOHSIUNG UNIVERSITY OF HOSPITALITY AND TOURISM   (Taiwan)

^e FISHERIES RESEARCH INSTITUTE   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Deep seawater drinking water; Lipid homeostasis; Liver lipid peroxidation; Nonalcoholic hepatosteatosis

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; DEEP SEAWATER DRINKING WATER; FAT DROPLET; FATTY ACID SYNTHASE; GLUTATHIONE; LIPID; LIVER PROTECTIVE AGENT; MALATE DEHYDROGENASE (DECARBOXYLATING); MALONALDEHYDE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 2;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; ELECTRODIALYSIS; FATTY LIVER; HAMSTER; LIPID DIET; LIPID OXIDATION; LIPID STORAGE; LIVER PROTECTION; LIVER SIZE; MALE; NONHUMAN; PROTEIN EXPRESSION; REVERSE OSMOSIS;

ANIMALS; CRICETINAE; DIET, HIGH-FAT; DRINKING WATER; GLUTATHIONE; LIPID METABOLISM; LIVER; MALE; MALONDIALDEHYDE; MESOCRICETUS; OXIDATION-REDUCTION; SEAWATER;

EID: 84872682814     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/j.jcma.2012.10.008     Document Type: Article

References (26)

1. Bedogni G., Bellentani S. Fatty liver: how frequent is it and why?. Ann Hepatol 2004, 3:63-65.
2. Torres D.M., Harrison S.A. Diagnosis and therapy of nonalcoholic steatohepatitis. Gastroenterology 2008, 134:1682-1698.
3. Vuppalanchu R., Chalasani N. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management. Hepatology 2009, 49:306-317.
4. Toyota T., Nakashima T. Comparison of the effects of water-soluble (EDTA) and particulate (chelex-100) synthetic ligands on the growth of phytoplankton population in the disphotic zone seawater. J Oceanogr 1998, 54:19-28.
5. Katsuda S., Yasukawa T., Nakagawa K., Miyake M., Yamasaki M., Katahira K., et al. Deep-sea water improves cardiovascular hemodynamics in Kurosawa and Kusanagi-Hypercholesterolemic (KHC) rabbits. Biol Pharm Bull 2008, 31:38-44.
6. Hwang H.S., Kim H.A., Lee S.H., Yun J.W. Antiobesity and antidiabetic effects of deep sea water on ob/ob mice. Mar Biotechnol 2009, 11:531-539.
7. Chang M.H., Tzang B.S., Yang T.Y., Yang H.C., Hsiao Y.C., Chen Y.C. Effects of deep-seawater on blood lipids and pressure in high-cholesterol dietary mice. J Food Biochem 2011, 35:241-259.
8. Hsu C.L., Chang Y.Y., Chiu C.H., Yang K.T., Wang Y., Fu S.G., et al. Cardiovascular protection of deep-seawater drinking water in high-fat/cholesterol fed hamsters. Food Chem 2011, 127:1146-1152.
9. Horton J.D., Goldstein J.L., Brown M.S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 2002, 109:1125-1131.
10. Fischer M., You M., Matsumoto M., Crabb D.W. Peroxisome proliferator-activated receptor α (PPARα) agonist treatment reverses PPARα dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice. J Biol Chem 2003, 278:27997-28004.
11. Matsuo K., Arai H., Muto K., Fukaya M., Sato T., Mizuno A., et al. The anti-obesity effect of the palatinose-based formula inslow is likely due to an increase in the hepatic PPAR-alpha and adipocyte PPAR-gamma gene expressions. J Clin Biochem Nutr 2007, 40:234-241.
12. Seo Y.S., Kim J.H., Jo N.Y., Choi K.M., Baik S.H., Park J.J., et al. PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes. J Gastroenterol Hepatol 2008, 23:102-109.
13. Yang S.F., Tseng J.K., Chang Y.Y., Chen Y.C. Flaxseed oil attenuates nonalcoholic fatty liver of hyperlipidemic hamsters. J Agric Food Chem 2009, 57:5078-5083.
14. Chang Y.Y., Chou C.H., Chiu C.H., Lin Y.L., Yang K.T., Weng W.L., et al. Preventive effects of taurine on development of hepatic steatosis induced by a high-fat/cholesterol-dietary habit. J Agric Food Chem 2011, 59:450-457.
15. Huang C.H., Chang Y.Y., Kang W.Y., Lin Y.L., Chang H.C., Chen Y.C. Fruiting body of Niuchangchih (Antrodia camphorata) protects livers against chronic alcohol-consumption damage. J Agric Food Chem 2010, 58:3859-3866.
16. Fang Y.J., Chiu C.H., Chang Y.Y., Chou C.H., Lin H.W., Chen M.F., et al. Taurine ameliorates alcoholic steatohepatitis via enhancing self-antioxidant capacity and alcohol metabolism. Food Res Int 2011, 44:3105-3110.
17. Adams L.A., Lindor K.D. Nonalcoholic fatty liver disease. Ann Epidemiol 2007, 17:863-869.
18. Bell L., Hslstenson C.E., Halstenson C.J. Cholesterol-lowering effects of calcium carbonate in patients with mild to moderate hypercholesterolemia. Arch Intern Med 1992, 152:2441-2444.
19. Kishimoto Y., Tani M., Uto-Kondo H., Saita E., Iizuka M., Sone H., et al. Effects of magnesium on postprandial serum lipid responses in healthy human subjects. Br J Nutr 2010, 103:469-472.
20. Reid I.R., Mason B., Horne A., Ames R., Clearwater J., Bava U., et al. Effects of calcium supplementation on serum lipid concentrations in normal older women: a randomized controlled trial. Am J Med 2002, 112:343-347.
21. Sun X., Zemel M.B. Calcium and dairy products inhibit weight and fat regain during ad libitum consumption following energy restriction in AP2-agouti transgenic mice. J Nutr 2004, 134:3054-3060.
22. Yoshioka S., Hamada A., Cui T., Yokota J., Yamamoto S., Kusunose M., et al. Pharmacological activity of deep-sea water: examination of hyperlipidemia prevention and medical treatment effect. Biol Pharm Bull 2006, 26:1552-1559.
23. Tzang B.S., Yang S.F., Fu S.G., Yang H.C., Sun H.L., Chen Y.C. Effects of dietary flaxseed oil on cholesterol metabolism of hamsters. Food Chem 2009, 114:1450-1455.
24. Adiga U., D'souza V., Kamath A., Mangalore N. Antitoxidant activity and lipid peroxidation in preeclampsia. J Chin Med Assoc 2007, 70:435-438.
25. Toyama T., Nakamura H., Harano Y., Yamauchi N., Morita A., Kirishima T., et al. PPARα ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats. Biochem Biophys Res Commun 2004, 324:697-704.
26. Miyamura M., Yoshioka S., Hamada A., Takuma D., Yokota J., Kusunose M., et al. Difference between deep seawater and surface seawater in the preventive effect of atherosclerosis. Biol Pharm Bull 2004, 27:1784-1787.